AMACR and ovarian clear cell cancer: In the present case, the immunohistochemical expression of the studied markers (p53, WT1, ER, PR, NapsinA, and AMACR) confirms the diagnosis of clear-cell ovarian carcinoma, excluding the possibility of metastasis from the other identified malignant tumors.